Side-by-side comparison of AI visibility scores, market position, and capabilities
Denver healthcare REIT (NYSE: DOC) $21B combined; Healthpeak + Physicians Realty Trust merger Mar 2024, life science labs (SF/SD/Boston) + 300+ MOBs, competing with Alexandria Real Estate and Ventas.
Healthpeak Properties, Inc. is a Denver, Colorado-based healthcare real estate investment trust — publicly traded on the New York Stock Exchange (NYSE: DOC) as an S&P 500 Real Estate component — owning, operating, and developing healthcare-focused real estate including life science laboratory buildings (biopharmaceutical R&D facilities in South San Francisco, San Diego, Boston), medical office buildings (outpatient care facilities adjacent to major hospital campuses), and continuing care retirement communities through approximately 400 employees. In March 2024, Healthpeak Properties (then trading as HCP/PEAK) completed its $21 billion merger of equals with Physicians Realty Trust (DOC — medical office REIT with 300+ medical outpatient buildings in 30+ states) — adopting Physicians Realty Trust's ticker symbol "DOC" and creating a $21 billion combined healthcare REIT with 60+ million square feet of life science labs, 18+ million square feet of medical office, and the most diversified healthcare real estate portfolio among public healthcare REITs. CEO Scott Brinker leads the combined company's strategy of capitalizing on the structural demand drivers for healthcare real estate: life science lab demand driven by NIH funding, private biopharma venture investment, and drug approval tailwinds — and medical office demand driven by the shift of healthcare delivery from hospital inpatient settings to outpatient ambulatory care facilities that require real estate closer to patient populations. Healthpeak's life science portfolio in the three dominant biotech clusters (San Francisco Bay Area, San Diego's Torrey Pines/UTC corridor, Boston's Kendall Square/Route 128 corridor) positions it in the markets where biopharma and biotech tenants require Class A laboratory space for drug discovery and development.
$2.74B revenue 2024 (+11% YoY); $732M Q1 2025 revenue (+12% YoY); 56th consecutive quarter double-digit growth; 134M+ monthly unique visitors Q4 2024; 6,400+ employees in 14 countries
CoStar Group is the leading provider of commercial real estate data, analytics, and marketplace platforms, founded in 1987 in Washington, D.C. by Andrew Florance. The company was built on the conviction that commercial real estate — one of the world's largest asset classes — was fundamentally underserved by reliable data, and that building a proprietary research infrastructure to collect, verify, and distribute property information would create a durable competitive moat. CoStar's core technology combines a massive field research organization with digital data collection tools to maintain the most comprehensive commercial real estate database in the world.\n\nCoStar's product portfolio spans multiple platforms serving different segments of the real estate market: CoStar for commercial real estate professionals, LoopNet for commercial property marketing, Apartments.com for multifamily rental search, Homes.com for residential real estate, and Ten-X for online commercial property auctions. This multi-platform strategy positions CoStar Group as the data and marketplace layer across every major real estate segment. The company attracted more than 134 million unique monthly visitors across its networks in Q4 2024, demonstrating the scale of its audience reach.\n\nCoStar Group reported $2.74 billion in revenue for 2024, an 11% year-over-year increase, marking its 56th consecutive quarter of double-digit revenue growth — a remarkable consistency streak in enterprise SaaS. The company's combination of proprietary data assets, marketplace network effects, and expanding residential real estate ambitions gives it multiple growth vectors as it targets the vast residential brokerage market that dwarfs its existing commercial business.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.